Print

ASINEX Ltd. Achieves Milestone In Collaboration With Biovitrum AB 
10/19/2005 5:09:30 PM

Moscow, Russia, 11th of July 2005 - ASINEX Ltd, a worldwide leader in lead generation and lead optimization announces the triggering of its first milestone payment as a part of a drug discovery collaboration with Biovitrum AB, a European Biotech company focusing on metabolic diseases R&D. ASINEX has achieved screening results which have met the set criteria of Biovitrum for an undisclosed GPCR target.
//-->